10050-TB-1 ADDITIONAL RAS/MAPK PATHWAY ACTIVATION ALLOWS CELLS TO DIFFERENTIATE DURING TUMORIGENESIS.
Shunichiro Miki, Tomoyuki Koga, Frank Furnari · 2023
Read 10050-TB-1 ADDITIONAL RAS/MAPK PATHWAY ACTIVATION ALLOWS CELLS TO DIFFERENTIATE DURING TUMORIGENESIS. by Shunichiro Miki, Tomoyuki Koga, Frank Furnari (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-10710633.txt.
Description
Shunichiro Miki, Tomoyuki Koga, and Frank Furnari report a laboratory study of glioblastoma, published in two thousand twenty-three. The work asks how activation of the RAS/MAPK signaling pathway changes tumor formation in cells at different stages of development.
The team grew human stem cells carrying several glioblastoma-linked mutations and turned them into neural stem cells and astrocytes. Adding the EGFRvIII gene sped tumor growth in stem cells and was required for tumors in astrocytes. Tumors from both cell types looked alike under RNA sequencing. The authors conclude that pathway activation lets even differentiated cells transform and form tumors.
Catalog record
| CREATOR | Shunichiro Miki, Tomoyuki Koga, Frank Furnari |
|---|---|
| YEAR | 2023 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 2 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |